Zynex Inc

NASDAQ:ZYXI USA Medical Distribution
Market Cap
$2.61 Million
Market Cap Rank
#35329 Global
#11517 in USA
Share Price
$0.09
Change (1 day)
+7.50%
52-Week Range
$0.03 - $2.69
All Time High
$25.72
About

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more

Zynex Inc (ZYXI) - Total Assets

Latest total assets as of September 2025: $45.32 Million USD

Based on the latest financial reports, Zynex Inc (ZYXI) holds total assets worth $45.32 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Zynex Inc - Total Assets Trend (1998–2024)

This chart illustrates how Zynex Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Zynex Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Zynex Inc's total assets of $45.32 Million consist of 61.6% current assets and 38.4% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 32.5%
Accounts Receivable $18.02 Million 14.8%
Inventory $13.92 Million 11.4%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $7.25 Million 5.9%
Goodwill $20.40 Million 16.7%

Asset Composition Trend (1998–2024)

This chart illustrates how Zynex Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Zynex Inc's current assets represent 61.6% of total assets in 2024, a decrease from 100.0% in 1998.
  • Cash Position: Cash and equivalents constituted 32.5% of total assets in 2024, up from 0.0% in 1998.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 1998.
  • Asset Diversification: The largest asset category is goodwill at 16.7% of total assets.

Zynex Inc Competitors by Total Assets

Key competitors of Zynex Inc based on total assets are shown below.

Company Country Total Assets
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
China CN¥67.71 Billion
Shenzhen Glory Medical Co Ltd
SHE:002551
China CN¥3.56 Billion
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
China CN¥15.33 Billion
Hanmi Science
KO:008930
Korea ₩1.45 Trillion
BCM Alliance Bhd
KLSE:0187
Malaysia RM147.86 Million
Qingdao Baheal Medical INC.
SHE:301015
China CN¥7.59 Billion
Excelsior Medical Co Ltd
TW:4104
Taiwan NT$18.80 Billion
CHC Healthcare Group
TW:4164
Taiwan NT$14.83 Billion

Zynex Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.98 - 3.25

Strong asset utilization - Zynex Inc generates 1.58x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -78.76% - 82.48%

Moderate ROA - For every $100 in assets, Zynex Inc generates $ 2.45 in net profit.

Zynex Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.47 3.94 6.23
Quick Ratio 0.32 3.15 5.38
Cash Ratio 0.00 0.00 0.00
Working Capital $-41.83 Million $ 58.48 Million $ 52.91 Million

Zynex Inc - Advanced Valuation Insights

This section examines the relationship between Zynex Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 34.84
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) -10.8%
Total Assets $122.08 Million
Market Capitalization $1.36 Million USD

Valuation Analysis

Below Book Valuation: The market values Zynex Inc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Zynex Inc's assets decreased by 10.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Zynex Inc (1998–2024)

The table below shows the annual total assets of Zynex Inc from 1998 to 2024.

Year Total Assets Change
2024-12-31 $122.08 Million -10.83%
2023-12-31 $136.90 Million +13.75%
2022-12-31 $120.35 Million -9.70%
2021-12-31 $133.27 Million +79.56%
2020-12-31 $74.22 Million +162.49%
2019-12-31 $28.28 Million +74.72%
2018-12-31 $16.18 Million +81.25%
2017-12-31 $8.93 Million +118.26%
2016-12-31 $4.09 Million +10.69%
2015-12-31 $3.70 Million -48.05%
2014-12-31 $7.11 Million -58.69%
2013-12-31 $17.22 Million -33.53%
2012-12-31 $25.91 Million +18.93%
2011-12-31 $21.79 Million +38.75%
2010-12-31 $15.70 Million +31.61%
2009-12-31 $11.93 Million +10.63%
2008-12-31 $10.78 Million +50.30%
2007-12-31 $7.18 Million +159.19%
2006-12-31 $2.77 Million +105.84%
2005-12-31 $1.34 Million +70.33%
2004-12-31 $789.60K +83.63%
2003-12-31 $430.00K +193.99%
2000-12-31 $146.26K +119788.52%
1999-12-31 $122.00 0.00%
1998-12-31 $122.00 --